Capecitabine is an oral fluoropyrimidine carbamate rationally designed to generate 5-Fluorouracil preferentially in tumour tissue through exploitation of high intratumoural concentrations of thymidine phosphorylase (TP). Here, TYMP is linked to neoplasm.